300
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Comparison of a One- versus Two-Week Treatment with Famciclovir Upon Reductions in Pain and Occurrence of Postherpetic Neuralgia in Herpes Zoster: A Randomized Open-Label Trial

, , &
Pages 721-726 | Received 08 Aug 2022, Accepted 16 Jan 2023, Published online: 02 Feb 2023

References

  • Sauerbrei A. Diagnosis, antiviral therapy, and prophylaxis of varicella-zoster virus infections. Eur J Clin Microbiol Infect Dis. 2016;35:723–734. doi:10.1007/s10096-016-2605-0
  • O’Connor KM, Paauw DS. Herpes zoster. Med Clin North Am. 2013;97:503–522. doi:10.1016/j.mcna.2013.02.002
  • Yawn BP, Saddier P, Wollan PC, St Sauver JL, Kurland MJ, Sy LS. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc. 2007;82:1341–1349. doi:10.4065/82.11.1341
  • Johnson R, McElhaney J, Pedalino B, Levin M. Prevention of herpes zoster and its painful and debilitating complications. Int J Infect Dis. 2007;11:S43–S48. doi:10.1016/S1201-9712(07)60021-6
  • Fashner J, Bell AL. Herpes zoster and postherpetic neuralgia: prevention and management. Virus. 2011;83:1432–1437.
  • Wu CL, Marsh A, Dworkin RH. The role of sympathetic nerve blocks in herpes zoster and postherpetic neuralgia. Pain. 2000;87:121–129. doi:10.1016/S0304-3959(00)00230-X
  • Kawai K, Gebremeskel BG, Acosta CJ. Systematic review of incidence and complications of herpes zoster: towards a global perspective. BMJ Open. 2014;4:e004833. doi:10.1136/bmjopen-2014-004833
  • Rasi A, Heshmatzade Behzadi A, Rabet M. The efficacy of time-based short-course Acyclovir therapy in treatment of postherpetic pain. J Infect Dev Ctries. 2010;4:754–760. doi:10.3855/jidc.849
  • Perry CM, Wagstaff AJ. Famciclovir: a review of its pharmacological properties and therapeutic efficacy in herpes virus infections. Drugs. 1995;50(2):396. doi:10.2165/00003495-199550020-00011
  • Stoopler ET, Balasubramanlam R. Topical and systemic therapies for oral and perioral herpes simplex virus infections. J Calif Dent Assoc. 2013;41:259–262.
  • Poirrier JE, DeMartino JK, Nagar S, et al. Burden of opioid use for pain management among adult herpes zoster patients in the US and the potential impact of vaccination. Hum Vaccin Immunother. 2022;2022:1–11.
  • Xue S, Yang WJ, Cao ZX, Sun T. Comparing the efficacy and safety of short-term spinal cord stimulation and pulsed radiofrequency for zoster-related pain: a systematic review and meta-analysis. Medicine. 2022;101:e29073.
  • Bian Z, Yu J, Tu M. Acupuncture therapies for postherpetic neuralgia: a protocol for a systematic review and Bayesian network meta-analysis. BMJ Open. 2022;12:e056632. doi:10.1136/bmjopen-2021-056632
  • Wood MJ, Johnson RW, McKendrick MW, et al. A randomized trial of Acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster. N Engl J Med. 1994;330:896–900. doi:10.1056/NEJM199403313301304
  • Andrei G, Snoeck R. Advances and perspectives in the management of varicella-zoster virus infections. Molecules. 2021;26:1132. doi:10.3390/molecules26041132